1.
Phạm TL, Lê HM, Phạm VH, Vũ VB, Nguyễn TD, Trần KC, et al. RESULT OF PEMBROLIZUMAB PLUS CHEMOTHERAPY IN THE FIRST-LINE THERAPY FOR DISTANT METASTATIC NON-SMALL-CELL LUNG CANCER WITH PD-L1 ≥1%, EGFR(-), ALK(-) AND ROS1(-). JPMP175 [Internet]. 2024 Mar. 30 [cited 2026 May 26];(37):13. Available from: https://jpmp175.vojs.vn/index.php/jpmp175/article/view/92